Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science and Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
School of Medicine, South China University of Technology, Guangzhou, China.
Front Immunol. 2022 Apr 20;13:860311. doi: 10.3389/fimmu.2022.860311. eCollection 2022.
Primary biliary cholangitis (PBC), an organ-specific autoimmune disease, is characterized by injury to small bile ducts, inflammatory cell infiltrates within the liver, progressive cholestasis, and in some cases, cirrhosis with unclear pathogenesis. We aimed to clarify the importance role of hepatic immunce cells in the pathogenesis of human and experimental PBC.The dominant-negative TGFβ receptor type II transgenic (dnTGFβRII) mice, a well-studied and established murine model of PBC were used to identify changes of immune cells, especially the pathogenic CD8 T cells. The high-throughput single-cell RNA sequencing technology were applied and found functional heterogeneity among the hepatic CD8 T cells subsets in dnTGFβRII mice. CD8 T cells were confirmed the key cells leading to the pathogenesis of PBC in dnTGFβRII mice, and identified the terminally differentiated CD8αα T cells and CD8αβ T cell subsets in the liver of dnTGFβRII mice. While terminally differentiated CD8αα T cells have higher cytokine production ability and cytotoxicity, the terminally differentiated CD8αβ T cells retain their proliferative profile. Our work suggests that there are developmental and differentiated trajectories of pathogenic CD8 T cell subsets in the pathogenesis of PBC. A further clarification of their roles would be helpful to our understanding of the pathogenesis of PBC and may potentially lead to identifying novel therapeutic modalities.
原发性胆汁性胆管炎(PBC)是一种器官特异性自身免疫性疾病,其特征为小胆管损伤、肝脏内炎症细胞浸润、进行性胆汁淤积,在某些情况下还会发展为肝硬化,但发病机制尚不清楚。我们旨在阐明肝免疫细胞在人类和实验性 PBC 发病机制中的重要作用。使用已被深入研究和广泛应用的 TGFβ 受体 II 型显性负突变(dnTGFβRII)转基因小鼠这一模型,来确定免疫细胞,尤其是致病性 CD8 T 细胞的变化。应用高通量单细胞 RNA 测序技术,我们在 dnTGFβRII 小鼠的肝内 CD8 T 细胞亚群中发现了功能异质性。CD8 T 细胞被证实是导致 dnTGFβRII 小鼠 PBC 发病的关键细胞,并鉴定出了 dnTGFβRII 小鼠肝脏中的终末分化 CD8αα T 细胞和 CD8αβ T 细胞亚群。虽然终末分化的 CD8αα T 细胞具有更高的细胞因子产生能力和细胞毒性,但终末分化的 CD8αβ T 细胞仍保持其增殖特性。我们的工作表明,在 PBC 的发病机制中,存在致病性 CD8 T 细胞亚群的发育和分化轨迹。进一步阐明它们的作用将有助于我们理解 PBC 的发病机制,并可能有助于确定新的治疗方法。